Rtw Investments »

Savara shares owned by Rtw Investments

Quarter-by-quarter ownership of Savara (SVRA) shares owned by Rtw Investments from 13F filings

Historical chart of Rtw Investments investment in Savara

Tip: Access up to 7 years of quarterly data

All positions including Savara held by Rtw Investments consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Savara by Rtw Investments

Quarter filed Position value Share count Share price at filing
2025-12-31 $36M 6.0M 6.03

More positions owned by Rtw Investments

Madrigal Pharmaceuticals (MDGL)
Insmed Com Par $.01 (INSM)
Ptc Therapeutics I (PTCT)
Argenx Se Sponsored Adr (ARGX)
Protagonist Therapeutics (PTGX)
Natera (NTRA)
RadNet (RDNT)
Tarsus Pharmaceuticals (TARS)
Cogent Biosciences (COGT)
Penumbra (PEN)
Irhythm Technologies (IRTC)
Apogee Therapeutics (APGE)
Apellis Pharmaceuticals (APLS)
ACADIA Pharmaceuticals (ACAD)
Establishment Labs Holdings Ord (ESTA)

View all positions for Rtw Investments

Top funds holding Savara

NEA Management Company
Bain Capital Life Sciences Investors
VR Adviser
Deerfield Management Company
TCG Crossover Management
Frazier Life Sciences Management
Vanguard Group
BlackRock
Polar Capital Holdings
Nantahala Capital Management
Rtw Investments
Marshall Wace
State Street Corporation
Woodline Partners
Vestal Point Capital

View all funds holding Savara